Truist Financial Corporation · NYSE (us_market)
Financial Services · Banks - Regional · United States
Truist Financial Corporation, a financial services company, provides banking and trust services in the Southeastern and Mid-Atlantic United States. The company operates through two segments, Consumer and Small Business Banking; and Wholesale Banking. Its deposit products include noninterest-bearing checking, interest-bearing checking, savings, and money market deposit accounts, as well as certificates of deposit and individual retirement accounts. The company also provides funding; asset management; credit card lending; home equity and mortgage lending; other direct retail lending; home mortgage lending; Investment brokerage services; mobile/online banking; payment solutions; point-of-sale lending; retail and small business deposit products; and small business lending. In addition, it offers asset-based lending, commercial deposit and treasury services; commercial lending; floor plan lending; derivatives; institutional trust services; insurance premium finance; international banking; investment banking and capital markets services; leasing; merchant services; mortgage warehouse lending; real estate lending; supply chain financing; and wealth management/private banking. The company was formerly known as BB&T Corporation and changed its name to Truist Financial Corporation in December 2019. Truist Financial Corporation was founded in 1872 and is headquartered in Charlotte, North Carolina.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-02-06$55.81 RISE2026-03-13$43.83 PEAK2026-04-30$51.50 83d | -21.5% 35d | Missed | Missed | — | — | +17.5% 48d | Missed |
DROP2025-02-06$48.15 RISE2025-06-13$38.97 PEAK2025-09-04$47.07 210d | -19.1% 127d | Missed | Missed | — | — | +20.8% 83d | Missed |
DROP2025-02-06$48.15 RISE2025-04-04$34.79 PEAK2025-07-02$45.03 146d | -27.7% 57d | Missed | Missed | — | — | +29.4% 89d | Missed |
DROP2023-07-19$35.59 RISE2023-10-23$27.03 PEAK2024-01-08$38.00 173d | -24.1% 96d | 2023-08-09 $31.47 | 2024-01-08 $38.00 | 87Deep Value | 71Deep Value | +40.6% 77d | +20.7% Held 152d |
DROP2023-02-13$49.10 RISE2023-06-23$30.00 PEAK2023-07-19$35.59 156d | -38.9% 130d | 2023-03-10 $38.84 | 2023-07-19 $35.59 | 76Deep Value | 74Deep Value | +18.6% 26d | -8.4% Held 131d |
DROP2023-02-02$50.39 RISE2023-05-04$26.21 PEAK2023-07-19$35.59 167d | -48.0% 91d | 2023-03-10 $38.84 | 2023-07-19 $35.59 | 76Deep Value | 74Deep Value | +35.8% 76d | -8.4% Duplicate trade Held 131d |
DROP2022-08-16$52.01 RISE2022-12-20$41.12 PEAK2023-02-02$50.39 170d | -20.9% 126d | 2022-10-28 $45.05 | 2023-02-02 $50.39 | 83Deep Value | 68Deep Value | +22.5% 44d | +11.9% Held 97d |
DROP2022-08-16$52.01 RISE2022-12-19$41.12 PEAK2023-02-02$50.39 170d | -20.9% 125d | 2022-10-28 $45.05 | 2023-02-02 $50.39 | 83Deep Value | 68Deep Value | +22.5% 45d | +11.9% Duplicate trade Held 97d |
DROP2022-08-16$52.01 RISE2022-10-20$40.42 PEAK2023-01-13$47.57 150d | -22.3% 65d | 2022-10-28 $45.05 | 2023-01-13 $47.57 | 83Deep Value | 79Deep Value | +17.7% 85d | +5.6% Held 77d |
DROP2022-03-29$60.56 RISE2022-07-14$45.20 PEAK2022-08-16$52.01 140d | -25.4% 107d | Missed | Missed | — | — | +15.1% 33d | Missed |
DROP2021-05-27$62.14 RISE2021-07-19$52.18 PEAK2021-10-08$60.83 134d | -16.0% 53d | Missed | Missed | — | — | +16.6% 81d | Missed |
DROP2020-06-08$46.37 RISE2020-09-23$35.43 PEAK2020-11-10$49.04 155d | -23.6% 107d | 2020-06-29 $36.74 | 2020-11-10 $49.04 | 86Deep Value | 62Deep Value | +38.4% 48d | +33.5% Held 134d |
DROP2020-03-02$48.81 RISE2020-07-09$33.61 PEAK2020-08-12$40.81 163d | -31.1% 129d | 2020-03-23 $25.69 | 2020-08-12 $40.81 | 97Deep Value | 78Deep Value | +21.4% 34d | +58.9% Held 142d |
DROP2020-01-23$56.36 RISE2020-05-15$31.35 PEAK2020-06-08$46.37 137d | -44.4% 113d | 2020-03-09 $34.51 | 2020-06-08 $46.37 | 89Deep Value | 71Deep Value | +47.9% 24d | +34.4% Held 91d |
DROP2020-01-02$56.67 RISE2020-03-23$25.69 PEAK2020-06-08$46.37 158d | -54.7% 81d | 2020-03-09 $34.51 | 2020-06-08 $46.37 | 89Deep Value | 71Deep Value | +80.5% 77d | +34.4% Duplicate trade Held 91d |
Xcel Energy Inc. (NASDAQ:XEL) is included among the Billionaire George Soros Stock Portfolio: 10 Best Stocks to Buy. On May 18, Truist lowered its price recommendation on Xcel Energy Inc. (NASDAQ:XEL) to $92 from $95. It reiterated a Buy rating on the shares. The change came as part of a broader research update on the […]
Woodward, Inc. (NASDAQ:WWD) is included among the Billionaire George Soros Stock Portfolio: 10 Best Stocks to Buy. On May 26, Susquehanna initiated coverage of Woodward with a Positive rating. It also set a $423 price target on the stock. In a research note, the analyst said that the company designs, manufactures, and services fluid, combustion, […]
CMS Energy Corporation (NYSE:CMS) is included among the Billionaire George Soros Stock Portfolio: 10 Best Stocks to Buy. On May 21, Morgan Stanley lowered its price recommendation on CMS Energy Corporation (NYSE:CMS) to $77 from $81. It reiterated an Equal Weight rating on the shares. The analyst said the firm updated its price targets for […]
Essex Property Trust, Inc. (NYSE:ESS) is included among the 10 Safe Stocks to Buy for the Long Term in 2026. On May 27, Truist raised the firm’s price recommendation on Essex Property Trust, Inc. (NYSE:ESS) to $286 from $273. It reiterated a Hold rating on the shares. The firm said it adjusted its model to […]
We recently compiled a list of the 10 Most Widely Held Stocks by Individuals in 2026. NVIDIA Corporation (NASDAQ:NVDA) is one of the most widely held stocks by individuals in 2026. TheFly reported on May 21 that Truist increased its price target on NVDA to $307 from $287 while maintaining a Buy rating on the […]
Flywire Corporation (NASDAQ:FLYW) is one of the best small cap tech stocks to buy according to hedge funds. JPMorgan upgraded Flywire Corporation (NASDAQ:FLYW) to Neutral from Underweight on May 21, lifting the price target on the company to $16 from $14. It told investors in a research note that the company’s execution on re-mixing the business […]
Immunovant, Inc. (NASDAQ:IMVT) is one of the best momentum stocks to buy according to analysts. Truist lifted the price target on Immunovant, Inc. (NASDAQ:IMVT) to $30 from $23 on May 22, maintaining a Hold rating on the shares. The firm told investors in a research note that it updated its model after the company reported fiscal […]
Truist called Viking a “differentiated player” in the crowded obesity market, highlighting its flagship VK2735 candidate and dual oral-plus-injectable GLP-1 strategy.
Analysts recently trimmed their fair value estimate for FTI Consulting to US$174.50 from US$176.50, a move of about 1% that keeps the modeled price target in focus. This adjustment sits alongside Street research that balances optimism about the current growth and margin framework with caution around a tougher consulting setup and AI related risks. As you read on, you will see how these changing targets fit into the broader narrative and what to watch as the story evolves. Analyst Price...
Cimpress is back in focus after its assessed fair value in one analyst model moved from US$102.50 to US$111.50, lifting the price target range implied by that framework. Street research has been unpacking what this change means, with attention on how refreshed assumptions are feeding into valuation and where that leaves you on risk versus reward. Read on to see how the evolving narrative around these revised targets can help you track the stock’s story from here. Analyst Price Targets don't...
NVIDIA stock has ten Wall Street buy ratings up to $330 from Wedbush, but institutional money is exiting and retail volume turned red.
Eli Lilly and Company (NYSE:LLY) is one of the best medical stocks to invest in according to billionaires. Eli Lilly and Company (NYSE:LLY) received a rating update from Truist on May 1, with the firm maintaining a Buy rating on the shares with a price target of $1,281. It stated that the company’s retatrutide Phase 3 […]
Eli Lilly and Company (NYSE:LLY) is one of the best medical stocks to invest in according to billionaires. Eli Lilly and Company (NYSE:LLY) received a rating update from Truist on May 1, with the firm maintaining a Buy rating on the shares with a price target of $1,281. It stated that the company’s retatrutide Phase 3 […]
Stryker Corporation (NYSE:SYK) is one of the best robotic surgery stocks to buy. Barclays cut the price target on Stryker Corporation (NYSE:SYK) to $394 from $469 on May 4, maintaining an Overweight rating on the shares. The firm told investors in a research note that the company’s fiscal Q1 results were mixed and below the […]
Stryker Corporation (NYSE:SYK) is one of the best robotic surgery stocks to buy. Barclays cut the price target on Stryker Corporation (NYSE:SYK) to $394 from $469 on May 4, maintaining an Overweight rating on the shares. The firm told investors in a research note that the company’s fiscal Q1 results were mixed and below the […]
Truist Financial’s updated fair value estimate now sits at US$55.67, up from US$54.82. This gives you a slightly higher reference point for where analysts place the stock’s long term worth. That shift comes as research firms debate whether current pricing still offers a margin of safety or already reflects more cautious views on growth and execution. As you read on, you will see how these moves in price targets fit into the broader story and what to watch as the narrative evolves. Analyst...
Truist Financial’s updated fair value estimate now sits at US$55.67, up from US$54.82. This gives you a slightly higher reference point for where analysts place the stock’s long term worth. That shift comes as research firms debate whether current pricing still offers a margin of safety or already reflects more cautious views on growth and execution. As you read on, you will see how these moves in price targets fit into the broader story and what to watch as the narrative evolves. Analyst...
Equity LifeStyle Properties, Inc. (NYSE:ELS) is one of the 10 Best Residential REITs to Buy in 2026. On May 11, 2026, Barclays lowered the firm’s price target on Equity LifeStyle Properties, Inc. (NYSE:ELS) to $68 from $71 and maintained an Overweight rating on the shares. The firm updated its residential REIT models following Q1 earnings […]
Equity LifeStyle Properties, Inc. (NYSE:ELS) is one of the 10 Best Residential REITs to Buy in 2026. On May 11, 2026, Barclays lowered the firm’s price target on Equity LifeStyle Properties, Inc. (NYSE:ELS) to $68 from $71 and maintained an Overweight rating on the shares. The firm updated its residential REIT models following Q1 earnings […]
Sun Communities, Inc. (NYSE:SUI) is one of the 10 Best Residential REITs to Buy in 2026. On May 14, 2026, Deutsche Bank lowered the firm’s price target on Sun Communities, Inc. (NYSE:SUI) to $133 from $138 and maintained a Hold rating on the shares. Truist also lowered the firm’s price target on Sun Communities, Inc. […]
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| TFC | -5.34% | -2.70% | -2.03% | +22.05% |
| XLF | -0.65% | +0.55% | -5.82% | +1.22% |
| Alpha (stock − sector) | -4.69% | -3.25% | +3.79% | +20.83% |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-17 | Bender Bradley D | Chief Risk Officer | M Option exercise(deriv) | 4,123 | — | +$0 |
| 2026-03-17 | Bender Bradley D | Chief Risk Officer | M Option exercise(deriv) | 2,895 | — | +$0 |
| 2026-03-17 | Bender Bradley D | Chief Risk Officer | M Option exercise(deriv) | 803 | — | +$0 |
| 2026-03-17 | Bender Bradley D | Chief Risk Officer | F Tax withholding | 2,306 | $43.83 | −$101.1K |
| 2026-03-17 | Bender Bradley D | Chief Risk Officer | M Option exercise | 4,123 | — | +$0 |
| 2026-03-17 | Bender Bradley D | Chief Risk Officer | F Tax withholding | 1,594 | $43.83 | −$69.9K |
| 2026-03-17 | Bender Bradley D | Chief Risk Officer | M Option exercise | 2,895 | — | +$0 |
| 2026-03-17 | Bender Bradley D | Chief Risk Officer | F Tax withholding | 437 | $43.83 | −$19.2K |
| 2026-03-17 | Bender Bradley D | Chief Risk Officer | M Option exercise | 803 | — | +$0 |
| 2026-03-17 | Lesher Kristin | Chief Whlse Banking Officer | F Tax withholding | 7,433 | $43.83 | −$325.8K |
| 2026-03-17 | Maguire Michael Baron | Chief Financial Officer | F Tax withholding | 7,951 | $43.83 | −$348.5K |
| 2026-03-17 | Powell Cynthia B | Corp. Controller & CAO | M Option exercise(deriv) | 1,929 | — | — |
| 2026-03-17 | Powell Cynthia B | Corp. Controller & CAO | F Tax withholding | 2,476 | $43.83 | −$108.5K |
| 2026-03-17 | Powell Cynthia B | Corp. Controller & CAO | M Option exercise | 1,929 | — | +$0 |
| 2026-03-17 | ROGERS WILLIAM H JR | Chairman and CEO | F Tax withholding | 32,861 | $43.83 | −$1.44M |
| 2026-03-17 | Stengel Scott A | Chief Legal Officer | F Tax withholding | 3,001 | $43.83 | −$131.5K |
| 2026-03-17 | Wilson Donta L | Chief Consumer & SB BK Officer | F Tax withholding | 10,204 | $43.83 | −$447.2K |
| 2026-02-26 | BANNER JENNIFER S | Director | A Grant / award(deriv) | 4,027 | — | +$0 |
| 2026-02-26 | Boyer K. David Jr. | Director | A Grant / award | 4,027 | — | +$0 |
| 2026-02-26 | Bundy Scanlan Agnes | Director | A Grant / award(deriv) | 4,027 | — | +$0 |
| 2026-02-26 | CLEMENT DALLAS S | Director | A Grant / award(deriv) | 4,027 | — | +$0 |
| 2026-02-26 | Haynesworth Linnie M | Director | A Grant / award(deriv) | 4,027 | — | +$0 |
| 2026-02-26 | MOREA DONNA S | Director | A Grant / award(deriv) | 4,027 | — | +$0 |
| 2026-02-26 | PATTON CHARLES A | Director | A Grant / award(deriv) | 4,027 | — | +$0 |
| 2026-02-26 | PRUZAN JONATHAN | Director | A Grant / award | 4,027 | — | +$0 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-17upcoming | 1.08 | — | — |
| 2026-04-17 | 1.00 | 1.09 | +9.40% |
| 2026-01-21 | 1.09 | 1.12 | +2.66% |
| 2025-10-17 | 0.99 | 1.06 | +6.70% |
| 2025-07-18 | 0.93 | 0.93 | +0.32% |
| 2025-04-17 | 0.86 | 0.89 | +2.97% |
| 2025-01-17 | 0.88 | 0.91 | +3.78% |
| 2024-10-17 | 0.90 | 0.97 | +7.55% |
| 2024-07-22 | 0.83 | 0.91 | +9.18% |
| 2024-04-22 | 0.80 | 0.90 | +11.84% |
| 2024-01-18 | 0.90 | 0.81 | -9.50% |
| 2023-10-19 | 0.83 | 0.84 | +1.74% |
| 2023-07-20 | 1.03 | 0.92 | -10.37% |
| 2023-04-20 | 1.15 | 1.09 | -4.87% |
| 2023-01-19 | 1.28 | 1.30 | +1.66% |
| 2022-10-18 | 1.23 | 1.24 | +1.21% |